15.07.2016
- A US federal judge has set Jun. 26, 2017 as the trial date for Martin Shkreli, the 33-year-old founder of Retrophin and Turing Pharmaceuticals and former CEO of KalaBios as well as...
08.06.2016
- Martin Shkreli, the 33-year-old former CEO of Turing Pharmaceuticals, has pleaded “not guilty” to a conspiracy charge accusing him of using employees and consultants to conceal his...
21.03.2016
- The former general counsel of Turing Pharmaceuticals said on Thursday that he and other executives had repeatedly objected to a plan by Martin Shkreli, then chief executive, to...
09.02.2016
- Martin Shkreli, the 32-year-old former CEO of Turing Pharmaceuticals who made negative headlines last year after jacking up the price of the toxmoplasmosis drug Daraprim...
22.12.2015
- Martin Shkreli, CEO of Turing Pharma, which made headlines by raising the price of the 62-year-old drug, Daraprim (pyrimethamine) from $13.50 to $700 a tablet shortly after...
